Stanley G Rockson
Overview
Explore the profile of Stanley G Rockson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
2725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rockson S, Skoracki R
Lymphat Res Biol
. 2023 Sep;
21(6):581-584.
PMID: 37729078
A recently completed clinical trial compared a novel nonpneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD) for the treatment of breast cancer-related lymphedema (BCRL); the study...
12.
13.
Kim D, Tian W, Wu T, Xiang M, Vinh R, Chang J, et al.
Circulation
. 2023 Aug;
148(16):1231-1249.
PMID: 37609838
Background: Lymphedema is a global health problem with no effective drug treatment. Enhanced T-cell immunity and abnormal lymphatic endothelial cell (LEC) signaling are promising therapeutic targets for this condition. Sphingosine-1-phosphate...
14.
Karaca-Mandic P, Solid C, Armer J, Skoracki R, Campione E, Rockson S
Cost Eff Resour Alloc
. 2023 Jul;
21(1):47.
PMID: 37516870
Background: Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms and...
15.
Nguyen D, Dionyssiou D, Zaitseva T, Zhou A, Sue G, Deptula P, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1214116.
PMID: 37469481
Secondary lymphedema is a common condition among cancer survivors, and treatment strategies to prevent or treat lymphedema are in high demand. The development of novel strategies to diagnose or treat...
16.
Kim D, Tian W, Wu T, Xiang M, Vinh R, Chang J, et al.
medRxiv
. 2023 Jul;
PMID: 37398237
Background: Lymphedema is a global health problem with no effective drug treatment. Enhanced T cell immunity and abnormal lymphatic endothelial cell (LEC) signaling are promising therapeutic targets for this condition....
17.
18.
19.
Friedman R, Johnson A, Shillue K, Fleishman A, Mistretta C, Magrini L, et al.
Lymphat Res Biol
. 2023 Apr;
21(5):488-494.
PMID: 37083501
Methods of conservative management for breast cancer-related lymphedema (BCRL) are burdensome in terms of time, cost, and convenience. In addition, many patients are not candidates for surgical treatment. Preliminary results...
20.
Rockson S, Karaca-Mandic P, Nguyen M, Shadduck K, Gingerich P, Campione E, et al.
Sci Rep
. 2023 Jan;
13(1):911.
PMID: 36650179
No abstract available.